Author:
Kremer Joel M.,Cohen Stanley,Wilkinson Bethanie E.,Connell Carol A.,French Jonathan L.,Gomez-Reino Juan,Gruben David,Kanik Keith S.,Krishnaswami Sriram,Pascual-Ramos Virginia,Wallenstein Gene,Zwillich Samuel H.
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference17 articles.
1. Treating inflammation with the Janus kinase inhibitor CP-690,550;Vijayakrishnan;Trends Pharmacol Sci,2011
2. Janus kinases in immune cell signaling;Ghoreschi;Immunol Rev,2009
3. Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis;Meyer;J Inflamm (Lond),2010
4. Li X Jesson M Lee J Hirsch J Saabye M Bonar S Characterization of a potent inhibitor of JAK kinases, CP-690,550, and inhibition of specific JAK/STAT pathways at efficacious exposures in a rodent model of arthritis 2008
5. The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo;Kremer;Arthritis Rheum,2009
Cited by
286 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献